1. Home
  2. CRSP vs AUGO Comparison

CRSP vs AUGO Comparison

Compare CRSP & AUGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CRSP

CRISPR Therapeutics AG

N/A

Current Price

$55.44

Market Cap

5.8B

Sector

Health Care

ML Signal

N/A

Logo Aura Minerals Inc.

AUGO

Aura Minerals Inc.

N/A

Current Price

$78.85

Market Cap

4.8B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CRSP
AUGO
Founded
2013
1946
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
4.8B
IPO Year
2016
2009

Fundamental Metrics

Financial Performance
Metric
CRSP
AUGO
Price
$55.44
$78.85
Analyst Decision
Buy
Buy
Analyst Count
22
10
Target Price
$87.56
★ $101.91
AVG Volume (30 Days)
★ 1.3M
895.4K
Earning Date
11-09-2026
11-05-2026
Dividend Yield
N/A
★ 2.38%
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $289,590,000.00
N/A
Revenue This Year
$1,063.30
$69.92
Revenue Next Year
$283.48
$20.87
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 9169.85
N/A
52 Week Low
$44.12
$29.11
52 Week High
$78.48
$110.32

Technical Indicators

Market Signals
Indicator
CRSP
AUGO
Relative Strength Index (RSI) 52.39 41.97
Support Level $50.56 $71.04
Resistance Level $60.04 $91.28
Average True Range (ATR) 2.83 3.66
MACD -0.03 -1.72
Stochastic Oscillator 51.06 6.06

Price Performance

Historical Comparison
CRSP
AUGO

About CRSP CRISPR Therapeutics AG

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. Crispr's first approved drug is Casgevy, which was developed in collaboration with Vertex Pharmaceuticals and targets sickle-cell disease and transfusion-dependent beta-thalassemia. The company is advancing a variety of gene editing programs in immuno-oncology, cardiovascular, and a stem cell-derived therapy to treat Type 1 diabetes.

About AUGO Aura Minerals Inc.

Aura Minerals Inc is a mid-tier gold and copper production company focused on the development and operation of gold and base metal projects in the Americas. The company's operating segments include: Minosa Mine, Apoena Mine, the Aranzazu Mine, Almas Mine, Borborema Mine and Serra Grande Mine. It derives maximum revenue from Aranzazu Mine. The company's growth projects include: Matupa in Brazil, and Era Dorada in Guatemala. whereas its exploration projects include: Carajas, in Brazil, and Tolda Fria in Colombia.

Share on Social Networks: